Back to News
May 6, 2026 4:00 PM

Why Is Cencora Stock Trading Lower On Wednesday?

Shares of Cencora Inc. (NASDAQ:COR) are trading lower on Wednesday as the company reported its fiscal 2026 second-quarter results and lowered its annual guidance.

Cencora Earnings Report Drives COR Selloff

The pharmaceutical solutions organization reported second-quarter adjusted earnings of $4.75, missing the consensus of $4.81.

Sales of $78.36 billion came in below the expectation of $81.09 billion.

Sales increased 3.8% year over year, primarily due to a 2.9% increase in revenue within the U.S. Healthcare Solutions segment and a 13% increase in revenue within the International Healthcare Solutions segment.

Read Also:

Cencora CFO Jim Cleary To Retire After Years Of Driving Growth

Updated Fiscal 2026 Guidance Signals Mixed Outlook

Cencora increased its fiscal 2026 adjusted earnings guidance from $17.45–$17.75 per share to $17.65-$17.90 compared to the consensus ...